GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Marketable Securities

Biomics Biopharma (ASX:BBM) Marketable Securities : A$0.00 Mil (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Biomics Biopharma's Marketable Securities for the quarter that ended in . 20 was A$0.00 Mil.


Biomics Biopharma Marketable Securities Historical Data

The historical data trend for Biomics Biopharma's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Marketable Securities Chart

Biomics Biopharma Annual Data
Trend
Marketable Securities

Biomics Biopharma Semi-Annual Data
Marketable Securities

Biomics Biopharma Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Biomics Biopharma  (ASX:BBM) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Biomics Biopharma Marketable Securities Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomics Biopharma (ASX:BBM) Business Description

Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines